Home / Resource Library / Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy

Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy

Study investigated the effect of TP53 mutations on prognosis in patients with DLBCL treated with CAR T-cell therapy.